266 related articles for article (PubMed ID: 15735566)
21. Should we eradicate Helicobacter pylori infection in patients receiving nonsteroidal anti-inflammatory drugs or low-dose aspirin?
Chan FK
Chin J Dig Dis; 2005; 6(1):1-5. PubMed ID: 15667550
[TBL] [Abstract][Full Text] [Related]
22. [Epidemiology and risk factors of gastroduodenal ulcer].
Kreiss C; Blum AL
Chirurg; 1996 Jan; 67(1):7-13. PubMed ID: 8851669
[TBL] [Abstract][Full Text] [Related]
23. Peptic ulcer disease today.
Yuan Y; Padol IT; Hunt RH
Nat Clin Pract Gastroenterol Hepatol; 2006 Feb; 3(2):80-9. PubMed ID: 16456574
[TBL] [Abstract][Full Text] [Related]
24. Effect of helicobacter pylori infection on the risk of upper gastrointestinal bleeding in users of nonsteroidal anti-inflammatory drugs.
Papatheodoridis GV; Papadelli D; Cholongitas E; Vassilopoulos D; Mentis A; Hadziyannis SJ
Am J Med; 2004 May; 116(9):601-5. PubMed ID: 15093756
[TBL] [Abstract][Full Text] [Related]
25. Eradication of Helicobacter pylori for the prevention of peptic ulcer rebleeding.
Gisbert JP; Calvet X; Feu F; Bory F; Cosme A; Almela P; Santolaria S; Aznárez R; Castro M; Fernández N; García-Grávalos R; Cañete N; Benages A; Montoro M; Borda F; Pérez-Aisa A; Piqué JM
Helicobacter; 2007 Aug; 12(4):279-86. PubMed ID: 17669099
[TBL] [Abstract][Full Text] [Related]
26. Role of Helicobacter pylori infection and nonsteroidal anti-inflammatory drug use in bleeding peptic ulcers in Japan.
Ootani H; Iwakiri R; Shimoda R; Nakahara S; Amemori S; Fujise T; Kikkawa A; Tsunada S; Sakata H; Fujimoto K
J Gastroenterol; 2006 Jan; 41(1):41-6. PubMed ID: 16501856
[TBL] [Abstract][Full Text] [Related]
27. Clinical trends in ulcer diagnosis in a population with high prevalence of Helicobacter pylori infection.
Pérez-Aisa MA; Del Pino D; Siles M; Lanas A
Aliment Pharmacol Ther; 2005 Jan; 21(1):65-72. PubMed ID: 15644047
[TBL] [Abstract][Full Text] [Related]
28. Helicobacter pylori and bleeding duodenal ulcer: prevalence of the infection and role of non-steroidal anti-inflammatory drugs.
Gisbert JP; Gonzalez L; de Pedro A; Valbuena M; Prieto B; Llorca I; Briz R; Khorrami S; Garcia-Gravalos R; Pajares JM
Scand J Gastroenterol; 2001 Jul; 36(7):717-24. PubMed ID: 11444470
[TBL] [Abstract][Full Text] [Related]
29. Role of Helicobacter pylori infection and non-steroidal anti-inflammatory drugs in peptic-ulcer disease: a meta-analysis.
Huang JQ; Sridhar S; Hunt RH
Lancet; 2002 Jan; 359(9300):14-22. PubMed ID: 11809181
[TBL] [Abstract][Full Text] [Related]
30. High incidence of mortality and recurrent bleeding in patients with Helicobacter pylori-negative idiopathic bleeding ulcers.
Wong GL; Wong VW; Chan Y; Ching JY; Au K; Hui AJ; Lai LH; Chow DK; Siu DK; Lui YN; Wu JC; To KF; Hung LC; Chan HL; Sung JJ; Chan FK
Gastroenterology; 2009 Aug; 137(2):525-31. PubMed ID: 19445937
[TBL] [Abstract][Full Text] [Related]
31. [Prevalence and incidence of NSAID-induced gastrointestinal ulcers and bleeding].
Yamagata M; Hiraishi H
Nihon Rinsho; 2007 Oct; 65(10):1749-53. PubMed ID: 17926519
[TBL] [Abstract][Full Text] [Related]
32. Analysis of the risk factors and their combinations in acute gastroduodenal ulcer bleeding: a case-control study.
Udd M; Miettinen P; Palmu A; Heikkinen M; Janatuinen E; Pasanen P; Tarvainen R; Mustonen H; Julkunen R
Scand J Gastroenterol; 2007 Dec; 42(12):1395-403. PubMed ID: 17994466
[TBL] [Abstract][Full Text] [Related]
33. Peptic ulcers and erosions are common in Israeli children undergoing upper endoscopy.
Egbaria R; Levine A; Tamir A; Shaoul R
Helicobacter; 2008 Feb; 13(1):62-8. PubMed ID: 18205668
[TBL] [Abstract][Full Text] [Related]
34. Effects of Helicobacter pylori and nonsteroidal anti-inflammatory drugs on peptic ulcer disease: a systematic review.
Papatheodoridis GV; Sougioultzis S; Archimandritis AJ
Clin Gastroenterol Hepatol; 2006 Feb; 4(2):130-42. PubMed ID: 16469671
[TBL] [Abstract][Full Text] [Related]
35. [Gastropathy caused by non-steroidal anti-inflammatory agents and its association with Helicobacter pylori].
Rodríguez-Hernández H; Jacobo-Karam JS; Jáquez-Quintana JO; Avila-Romero HG; Galván-Román L; Lara-Miranda SC; Sánchez-Anguiano LF
Rev Invest Clin; 2003; 55(3):254-9. PubMed ID: 14515669
[TBL] [Abstract][Full Text] [Related]
36. Long-term follow-up of patients with gastric outlet obstruction related to peptic ulcer disease treated with endoscopic balloon dilatation and drug therapy.
Cherian PT; Cherian S; Singh P
Gastrointest Endosc; 2007 Sep; 66(3):491-7. PubMed ID: 17640640
[TBL] [Abstract][Full Text] [Related]
37. Dominant cagA/vacA genotypes and coinfection frequency of H. pylori in peptic ulcer or chronic gastritis patients in Zhejiang Province and correlations among different genotypes, coinfection and severity of the diseases.
Chen XJ; Yan J; Shen YF
Chin Med J (Engl); 2005 Mar; 118(6):460-7. PubMed ID: 15788126
[TBL] [Abstract][Full Text] [Related]
38. Contribution of Helicobacter pylori infection to the risk of peptic ulcer bleeding in patients on nonsteroidal anti-inflammatory drugs, antiplatelet agents, anticoagulants, corticosteroids and selective serotonin reuptake inhibitors.
Venerito M; Schneider C; Costanzo R; Breja R; Röhl FW; Malfertheiner P
Aliment Pharmacol Ther; 2018 Jun; 47(11):1464-1471. PubMed ID: 29655196
[TBL] [Abstract][Full Text] [Related]
39. Nonsteroidal anti-inflammatory drug use is a significant cause of peptic ulcer disease in a tertiary hospital in Singapore: a prospective study.
Ong TZ; Hawkey CJ; Ho KY
J Clin Gastroenterol; 2006 Oct; 40(9):795-800. PubMed ID: 17016134
[TBL] [Abstract][Full Text] [Related]
40. [Should Helicobacter pylori infection be tested and eradicated in patients treated or about to be treated with aspirin or nonsteroidal anti-inflammatory drugs?].
Thiéfin G
Gastroenterol Clin Biol; 2003 Mar; 27(3 Pt 2):415-26. PubMed ID: 12700498
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
